These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 16847412)
21. Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial. Valantin MA; Lanoy E; Bentata M; Kalmykova O; Boutekadjirt A; Allavena C; Rozenbaum W; Peytavin G; Amellal B; Calvez V; Costagliola D; Katlama C; HIV Med; 2008 Oct; 9(8):625-35. PubMed ID: 18624724 [TBL] [Abstract][Full Text] [Related]
22. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688 [TBL] [Abstract][Full Text] [Related]
23. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. McComsey GA; Walker UA; Budhathoki CB; Su Z; Currier JS; Kosmiski L; Naini LG; Charles S; Medvik K; Aberg JA; AIDS; 2010 Oct; 24(16):2507-15. PubMed ID: 20827170 [TBL] [Abstract][Full Text] [Related]
33. [(13)C]Methionine breath test as a marker for hepatic mitochondrial function in HIV-infected patients. Sternfeld T; Lorenz A; Schmid M; Schlamp A; Demmelmair H; Koletzko B; Bogner JR AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1243-8. PubMed ID: 20001311 [TBL] [Abstract][Full Text] [Related]
34. Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors. Pao D; Watson C; Peters B; Lucas SB; Miller RF Sex Transm Infect; 2001 Oct; 77(5):381-4. PubMed ID: 11588287 [No Abstract] [Full Text] [Related]
35. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Lauterburg BH; Liang D; Schwarzenbach FA; Breen KJ Hepatology; 1993 Mar; 17(3):418-22. PubMed ID: 8444415 [TBL] [Abstract][Full Text] [Related]
36. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir]. de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909 [TBL] [Abstract][Full Text] [Related]
37. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828 [TBL] [Abstract][Full Text] [Related]
38. Impact of antiretroviral treatment on (13) C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. Banasch M; Frank J; Serova K; Knyhala K; Kollar S; Potthoff A; Brockmeyer NH; Goetze O HIV Med; 2011 Jan; 12(1):40-5. PubMed ID: 20500232 [TBL] [Abstract][Full Text] [Related]
39. HIV and mitochondrial toxicity in children. Foster C; Lyall H J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978 [TBL] [Abstract][Full Text] [Related]
40. Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. Brown TT; Chu H; Wang Z; Palella FJ; Kingsley L; Witt MD; Dobs AS AIDS; 2007 Aug; 21(13):1731-8. PubMed ID: 17690571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]